跳至主要内容
临床试验/EUCTR2019-004841-34-FI
EUCTR2019-004841-34-FI进行中(未招募)1 期

Selective laser trabeculoplasty versus eye drops for first line treatment of exfoliation ocular hypertension or glaucoma: a randomised clinical trial

Mika Harju0 个研究点目标入组 112 人开始时间: 2020年6月25日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • age of 50 –100 years, possibility to attend period of 12 months, exfoliation, newly diagnosed exfoliation glaucoma by EGS (European glaucoma society) guidelines or ocular hypertensio TA 24 mmHg or more, eye pressure less than 35 mmHg.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 82

排除标准

  • advanced glaucoma, target IOP less than 15, starting eye pressure 35 or more, eye vision 0.2 or worse, angle closure, unable to use eye drops, significant cataract, other active eye disease, previous intraocular operation excluding uncomplicated cataract surgery 1 year ago or earlier, clinical significant macular edema, intraocular injections to wet AMD, proliferative diabetic retinopathy, intraocular tumor, IOL luxation, active uveitis, serious other medical condition, participating in other clinical trial

研究者

发起方
Mika Harju

相似试验